EDUCATIONAL DINNER: Byfavo©—A Short-Acting Sedative for Procedures 30 Minutes or Less

In the US, the number of noninvasive and minimally invasive procedures has grown exponentially.1,2 More than 40 million procedures are being performed annually in a diverse range of therapeutic areas for which proceduralsedation is required.2-7 Acacia Pharma is pleased to present you with the first sedative to market in 20 years—Byfavo.8,9 Byfavo© (remimazolam) is a benzodiazepine intentionally designed as a rapid onset, rapid offset sedative that may be used across many procedures and adult patient types.  Click here to download the full program information.

Learning Objectives:

• Explore the current procedural sedation landscape
• Discuss the design of ester-based, soft drugs and how they are metabolized
• Gain knowledge of the clinical pharmacology, safety, and efficacy of Byfavo for use in adults